Improving Acute Kidney Injury Outcomes Following Percutaneous Coronary Intervention Procedures Through Targeted Clinical and Documentation Improvements
Acute kidney injury (AKI) is a serious complication following percutaneous coronary intervention (PCI), resulting in increased morbidity, prolonged hospitalization, and higher healthcare costs. In 2023, the University of California Davis (UCD) Heart & Vascular Center identified a PCl-related AKI rate above national benchmarks (9.88%; observed-to-expected [O/E] ratio 1.16), prompting a multidisciplinary quality improvement initiative.
Increasing Next Day Discharge (NDD) after Transcatheter Aortic Valve Replacement (TAVR) through targeted clinical interventions and documentation improvements
Reduced length of stay delivers meaningful clinical and financial value to both patients and hospitals. Most importantly, it benefits patients, supporting safer, more efficient recovery and a quicker return home. It also creates an opportunity to streamline assessment practices and more clearly identify patients who are appropriate candidates for next-day discharge (NDD). At the same […]
Enhancing Value in TAVR Programs: Financial Stewardship in a Shifting Healthcare Landscape
For high-cost, narrow margin procedures such as TAVR, deliberate integration of clinical, operational, and financial analytics is essential to support value-based care and long-term program viability. Clinical excellence alone is not sufficient; aligning quality outcomes with operational and financial analytics is critical to delivery truly value-based structural heart care.
Improving Same Day Discharge Process After Outpatient Percutaneous Coronary Interventions
A structured, multidisciplinary design of the outpatient PCI care pathway can safely and significantly increase same day discharge utilization, even in the setting of rising procedural volumes. Aligning workflows with evidence-based criteria and continuously benchmarking performance enables sustainable improvement without compromising patient safety.
Beyond the AI Hype: Why Healthcare Needs More Than Another SaaS Platform
Biome’s leadership team explores the realities and limitations of AI in healthcare, cutting through the hype to examine how technology can turn data into meaningful action. The conversation addresses clinical context, patient engagement, data governance, and why responsible, integrated AI must complement, not replace, human expertise. Welcome to the podcast!
Communicating Cardiovascular Successes and Needs: How to Gain Leadership Buy-In
Join us to explore how top healthcare institutions are driving performance improvement in advancing cardiovascular care. Today we discuss an essential but often an overlooked topic: how cardiovascular leaders can effectively communicate program successes and challenges to hospital leadership to gain support and buy-in. Welcome to the podcast!
Heart Health at a Crossroads: Addressing the Pervasive Burden of Delayed Care
Despite major advances in cardiovascular technology, outcomes suffer when those tools aren’t fully integrated into care systems or accessible to patients. This gap is especially evident in severe aortic stenosis, where many patients experience delayed diagnosis and referral, even though effective treatments like TAVR exist, leading to worse outcomes and higher costs. To fix this, […]
2026 Vision: From Insight to Impact – Advancing Cardiovascular Performance Through Precision, Partnership, and Purpose
Explore the trends reshaping cardiovascular care, how leading programs are responding, and the critical role of integrated, timely data in sustaining performance. This paper brings those insights together into Biome’s 2026 Vision: helping cardiovascular programs achieve top-tier clinical outcomes, protect contribution margin, and act on insights faster and more precisely—by treating quality improvement as a […]
How Leading Health Systems Are Modernizing Insights Workflows, and Governance To Drive Sustainable Performance
As cardiovascular programs confront rising complexity, leading systems are unifying clinical, financial, and operational data to drive more reliable decisions, stronger governance, and measurable improvements across the CVSL.